Related Experiment Video
Updated: May 22, 2026

Induction of Ocular Surface Inflammation and Collection of Involved Tissues
Published on: August 4, 2022
Cornea biomechanics and biometric evaluations in immunoglobulin G4-related ophthalmic disease
Kenneth Ka Hei Lai1,2, Fatema Mohamed Ali Abdulla Aljufairi2,3, Jake Uy Sebastian2,4
1Department of Ophthalmology and Visual Sciences, Prince of Wales Hospital, Hong Kong Special Administrative Region, Hong Kong, China.
Purpose:
To evaluate the corneal biomechanical and biometric properties in immunoglobulin G4-related ophthalmic disease (IgG4-ROD) patients.
Setting:
Ethnic Han Chinese biopsy-proven IgG4-ROD patients from a territory wide cohort and sex-, age-, smoking- and lens status-matched healthy controls.
Design:
A case-controlled (1:1) study.
Methods:
Corvis ST analyzer and IOL Master 700 biometry assessment.
Results:
Sixty-seven eyes from 67 patients with IgG4-ROD (41 = males), aged 63.9 ± 13.1 years and 67 right eyes from 67 healthy ethnically Han Chinese controls were recruited. IgG4-ROD eyes were associated with a more negative applanation 2 velocity (-0.30 versus -0.27 m/s, P = 0.0143), and reduced radius of curvature (7.48 versus 7.98 mm, P = 0.0136). There was no difference in intraocular pressure, applanation 1 length, applanation 1 velocity, applanation 2 length, deformation amplitude and peak distance. Corneal astigmatism was greater in IgG4-ROD eyes (-1.2 versus -0.9 D, P = 0.0132), and the deep axis is along 90.2 degree. There is no difference in the steep and flat keratometry, deep axis, lens thickness, cornea thickness, and anterior chamber depth.
Conclusions:
We found multiple corneal changes in biomechanics and fine structures in a cohort of biopsy-proven IgG4-ROD with potential long-term implications in ocular surface functions. A longitudinal follow-up would be useful to identify the clinical implications and observe if these changes improve with treatments.
More Related Videos
Related Concept Videos
Microbiome of the Eye
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...

